Concepedia

Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial

Benjamin Diamond, Neha Korde, Alexander M. Lesokhin, Eric L. Smith, Urvi A. Shah, Sham Mailankody, Malin Hultcrantz, Hani Hassoun, Sydney X. Lu, Carlyn Tan,

The Lancet Haematology · 2021 · 95 citations · 21 references

DOI

Concepts

References

21

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

, , +12

A note on quantifying follow-up in studies of failure time

M. Schemper, Terry L. Smith · Controlled Clinical Trials · 1996 · 2.5K citations

, , +7

Improved survival in multiple myeloma and the impact of novel therapies

Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri et al. · Blood · 2007 · 2.3K citations · Full text

, , +14

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text

, , +13

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

, , +15